Ambenonium Chloride

安贝氯铵

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAmbenonium Chloride
Drug Alias Name氯化阿伯农ambenonii chloridum酶抑宁cloruro de ambenonio酶斯的明 +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsMyasthenia Gravis
Global Approved IndicationsMyasthenia Gravis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1956/05/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Aventis U.S. Llc
Active IndicationsN/A
Inactive IndicationsMyasthenia Gravis

Other Information

ATC CodeN07AA30